Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rli (RLI) Cash & Equivalents (2016 - 2026)

Rli has reported Cash & Equivalents over the past 18 years, most recently at $49.1 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 81.54% year-over-year to $49.1 million; the TTM value through Mar 2026 reached $49.1 million, up 81.54%, while the annual FY2025 figure was $4.7 billion, 11620.58% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $49.1 million at Rli, down from $4.7 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.7 billion in Q4 2025 and troughed at $16.7 million in Q2 2023.
  • A 5-year average of $355.0 million and a median of $44.6 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: plummeted 97.45% in 2023 and later soared 11620.58% in 2025.
  • Year by year, Cash & Equivalents stood at $22.8 million in 2022, then surged by 59.63% to $36.4 million in 2023, then rose by 9.24% to $39.8 million in 2024, then soared by 11620.58% to $4.7 billion in 2025, then crashed by 98.95% to $49.1 million in 2026.
  • Business Quant data shows Cash & Equivalents for RLI at $49.1 million in Q1 2026, $4.7 billion in Q4 2025, and $52.6 million in Q3 2025.